Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
IslandWatch Newsletter
News
Filter by Year:
2024
2023
2022
2021
2020
6-Nov-2023
Island Pharmaceuticals gains ISLA-101 study ethics approval for dengue fever
6-Nov-2023
Island Pharma welcomes green light for ISLA-101 clinical study
1-Nov-2023
Island Pharmaceuticals granted Australian patent for ISLA-101
27-Sep-2023
Island Pharmaceuticals CEO and Managing Director Dr David Foster on ausbiz
26-Sep-2023
Island Pharma gearing up to start ISLA-101 trial for dengue fever
25-Sep-2023
Island Pharmaceuticals readies for ISLA-101 trial for dengue fever
13-Sep-2023
Island Pharmaceuticals secures key US patent for dengue fever treatment
7-Jul-2023
$US1.3m grant for dengue fever study
6-Jul-2023
Island Pharmaceuticals secures US grant funding to support clinical development of dengue fever candidate
24-May-2023
Island Pharmaceuticals sees tremendous opportunity for mosquito-borne virus program
Previous
1
2
3
Next
.png){kind=logo}
